AZTH $142.87 +2.41%
S&P 500 $5,382.40 +0.82%
NASDAQ $16,742.18 +1.15%
10Y Treasury 4.28% -0.05%
Crude (WTI) $78.42 +1.30%
Gold $2,341.60 +0.45%
EUR/USD 1.0842 -0.12%
BTC/USD $67,240 +3.20%
AZTH $142.87 +2.41%
S&P 500 $5,382.40 +0.82%
NASDAQ $16,742.18 +1.15%
10Y Treasury 4.28% -0.05%
Crude (WTI) $78.42 +1.30%
Gold $2,341.60 +0.45%
EUR/USD 1.0842 -0.12%
BTC/USD $67,240 +3.20%
NASDAQ: AZTH

Investor Relations

Transparency, disciplined capital allocation, and long-term value creation across 47 global industries.

AZTH $142.87 ▲ 2.41%
Market Cap
$1.82T
Global Large Cap
P/E Ratio (TTM)
28.4
Industry Avg: 24.1
Dividend Yield
1.82%
Quarterly Payout
ROIC (5yr Avg)
14.2%
Consistent Growth
Debt / Equity
0.42
Prudent Leverage
Free Cash Flow
$18.4B
FY 2025
Stock Performance
Financial Highlights

Consolidated Performance

d class="num" style="color: var(--success)">+13.1%
Metric FY 2025 FY 2024 FY 2023 Y/Y Change
Total Revenue 94.2B 86.5B 78.1B +8.9%
Gross Profit 38.6B 34.2B 29.8B +12.8%
Operating Income 22.4B 19.8B 17.2B
Net Income 16.1B 14.3B 12.5B +12.6%
Diluted EPS 5.04 4.48 3.92 +12.5%
Dividends / Share 2.60 2.40 2.20 +8.3%
Feb 12, 2026
Q4 2025 Earnings Call
Webcast & Transcript
Register →
Mar 24, 2026
Annual Shareholder Meeting
Zenth Tower, Neo Geneva
Proxy Statement →
May 14, 2026
Aevum Zenth Investor Day
Strategic Outlook & Capital Allocation
Details →
Feb 08, 2026
10-K Annual Report 2025
Full financial statements & MD&A
Download PDF →
Nov 07, 2025
10-Q Quarterly Report Q3
Unaudited financials & segment data
Download PDF →
Oct 15, 2025
2025 ESG & Sustainability Report
Net-zero pathways & governance metrics
View Report →
Jan 28, 2026
Aevum Zenth Announces $4.2B Share Buyback Authorization
Board approves enhanced capital return program
Read →
Jan 14, 2026
Zenth Health Sciences Receives FDA Breakthrough Therapy Designation
Gene therapy platform advances to Phase 3 trials
Read →
Dec 10, 2025
Aevum Energy Breaks Ground on 2.4GW Fusion Pilot Plant
Next-gen clean energy milestone achieved
Read →
Corporate Governance

Board & Oversight

12
Board Directors
  • Audit & Risk Committee
  • Compensation & ESG
  • Corporate Governance
  • Strategy & Acquisitions
58%
Independent Directors
  • Lead Independent Director
  • Annual Board Evaluation
  • Direct Access to Management
42%
Diverse Representation
  • Gender & Ethnic Diversity
  • International Experience
  • Industry Sector Balance

Investor & Media Inquiries

Our Investor Relations team is available to assist with analyst requests, media interviews, and shareholder communications.

IR Department ir@aevumzenth.com
Phone +41 22 700 8000
Mailing Address Zenth Tower, 1001 Innovation Blvd
Neo Geneva, Global HQ
Transfer Agent Equiniti Trust Company